Position in NVS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$603,842
+$72,425 QoQ
Shares Held
3,853
+10.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.73%
of 13F equity value
Holder Rank
#807
of 1,603 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Expressive Wealth LLC holds $5,161,628 across 7 Drug Manufacturers - General names. NVS ranks #4 (11.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
986 | $1,182,638 | |
| 2 | JNJ |
Johnson & Johnson
|
4,429 | $1,124,833 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
6,869 | $867,829 | |
| 4 | NVS |
Novartis AG
This page
|
3,853 | $603,842 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
9,042 | $521,000 | |
| 6 | ABBV |
AbbVie Inc.
|
1,722 | $433,324 | |
| 7 | MRK |
Merck & Co., Inc.
|
3,332 | $428,162 |
All Filings in NVS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $603,842 | 3,853 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $531,417 | 3,479 | Shares | Sole | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||